• Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 17 Feb 2025 01:56:12   America/Chicago


    Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat February 17, 2025 Share Link copied to clipboard. Kymera Therapeutics, Inc. ( NASDAQ:KYMR - Get Free Report ) has receiv
    Read more...
Share on,